Stocks in play: Theralase® Technologies Inc.
Has executed a Collaborative Research Agreement with the National Microbiology Laboratory, Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 ("COVID-19") vaccine. Theralase® Technologies Inc. shares V.TLT are trading up $0.01 at $0.26.
Read: